CN102070786B - Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof - Google Patents
Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof Download PDFInfo
- Publication number
- CN102070786B CN102070786B CN2009102376051A CN200910237605A CN102070786B CN 102070786 B CN102070786 B CN 102070786B CN 2009102376051 A CN2009102376051 A CN 2009102376051A CN 200910237605 A CN200910237605 A CN 200910237605A CN 102070786 B CN102070786 B CN 102070786B
- Authority
- CN
- China
- Prior art keywords
- solution
- sodium
- mucinase
- alginate
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The invention discloses hyaluronic acid-sodium alginate composite hydrogel and a preparation method thereof. The composite hydrogel is prepared from the following steps of: (1) dissolving hyaluronic acid and sodium alginate into water to obtain a solution 1; (2) adding a cross-linking agent to the solution 1, and regulating the pH value to be 4.0-5.5 with a buffer solution to obtain a solution 2; (3) adding a carboxyl activating agent to the solution 2 and stirring; and regulating and controlling the pH value of the solution 2 to be 2.0-5.5 in the stirring process until gel is formed to obtain the hyaluronic acid-sodium alginate composite hydrogenl. The invention provides a new approach for the modification of the hyaluronic acid, and the composite modified compound prepared by using the method has the advantages of higher mechanical property, capacity of resisting enzymatic degradation of the hyaluronic acid, biocompatibility, and the like and has potential application in the aspects of surgical operations and tissue engineering.
Description
Technical field
The present invention relates to a kind of mucinase-sodium-alginate composite aquogel and preparation method thereof.
Background technology
Mucinase (hyaluronic acid HA) is a kind of linearity, unbranched acidic mucopolysaccharide, alternately forms repeatedly by N-acetylglucosamine and D-glucuronic acid, and be the very high medicine of a kind of value, cosmetic material.HA has good hydrophilicity, biocompatibility and moisture-keeping functions, is widely used in being described as natural moisturizing factor in the makeup.HA also has good biocompatibility, does not produce rejection in vivo.Because the physicochemical property such as rheological property, oilness and biocompatibility that HA is unique, HA can be used as resilient material and is applied to eye surgery, the treatment bone and joint diseases, and have the wound healing of promotion and certain anticancer effect.HA also has vital role in medicament slow release, post-operation adhesion preventing and organizational project.
But mechanical properties is relatively poor, be prone in vivo by Unidasa fast drawbacks limit such as degraded mucinase in clinical application.For physics, the chemicalstability of improving HA, keep not having in its natural biocompatibility, biodegradability and the body characteristic of rejection simultaneously, people adopt number of ways that its hydroxyl and carboxyl are carried out modifying and decorating.That chemical modification method comprises is crosslinked, grafting, esterification and composite modified etc.At present, owing to the composite modified initial characteristic of two kinds of raw materials that often can keep receives people's attention.For composite modified, many macromolecular substance form crosslinked through the carboxyl of carboxyl or hydroxyl and HA.The material of success composite crosslinking comprises Xylo-Mucine, collagen, gelatin, POLYACTIC ACID, chitosan etc.Sodium-alginate (sodium alginate; Be called for short SAL) be a kind ofly to pass through 1 by α-L-guluronic acid and beta-D-mannuronic acid; The acidic mucopolysaccharide that the 4-glycosidic link is formed by connecting is widely used in food-processing, field of medicaments, comprises slow releasing carrier of medication, cell cultures etc.SAL has excellent biological compatibility, in case after forming gel, just have mechanical properties preferably.SAL and other polysaccharide have been seen in report like the mixture of chitosan, CHS etc., also have the people that the mixture of SAL-HA has been carried out rheol investigation, but this mixture only are the mixed solutions of two kinds of polymer substances.
Summary of the invention
The purpose of this invention is to provide a kind of mucinase-sodium-alginate composite aquogel and preparation method thereof.
Mucinase provided by the present invention (HA) and sodium-alginate (SAL) composite aquogel are to prepare according to the method that comprises the steps:
1) mucinase and sodium-alginate is soluble in water, obtain solution 1,
2) linking agent is added in the said solution 1, and use buffered soln adjusting pH value to be 4.0-5.5, obtain solution 2;
3) in said solution 2, add carboxyl activator and stirring, the pH value of regulating said solution 2 with buffered soln in the whipping process until the formation gel, promptly obtains mucinase and sodium-alginate composite aquogel at 2.0-5.5.
In the above-mentioned solution 1, the mass ratio of mucinase and sodium-alginate can be 1: 4-4: 1, and the preferred mass ratio is 1: 2.In the solution 1, the concentration sum of mucinase and sodium-alginate can be 0.5-1.5g/100ml, is preferably 1.0g/100ml.
Above-mentioned steps 2) linking agent described in can be selected from following at least a: adipic dihydrazide (ADH), and polyoxyethylene glycol (PEG), LUTARALDEHYDE and divinylsulfone (GTA) are preferably adipic dihydrazide (ADH); The proportioning of the add-on of said linking agent and said solution 1 can be 0.1g-1.0g: 100mL is preferably 0.52g: 100mL.
The activator of carboxyl described in the step 3) can be selected from following at least a: carbodiimide (EDC), N-hydroxy-succinamide (NHS) and N, N, N ", " Tetramethyl Ethylene Diamine (TEMED) is preferably carbodiimide to N; The proportioning of the addition of said carbonization imines and said solution 2 can be 10mmol-100mmol: 1L is preferably 50mmol: 1L.
Stir described in the step 3) and can under 15 ℃ of-40 ℃ of conditions, carry out, be preferably 20 ℃-30 ℃; Need to use the pH value of buffered soln regulation and control solution 2 to be 2.0-5.5 in the said whipping process, preferred pH value is 4.75.During stirring, the rotating speed of stirring should be unsuitable too fast, avoids causing forming behind the gel thinning.
Above-mentioned steps 2) with step 3) in used buffered soln identical, said buffered soln can be selected from following any one: phosphate buffer soln, citrate buffer solution and acetate buffer solution; The concentration of said buffered soln can be 0.01-0.5mol/L, and the pH value is 2.0-4.5, is preferably acetate buffer solution, and most preferable concentrations is 0.1mol/L, and the pH value is 3.6 acetate buffer solution.
Method of the present invention also comprises the step that mucinase that step 3) is obtained and sodium-alginate composite aquogel wash.Washing times should not be less than 5 times, and the gel that slowly overturns during washing is removed so that residual reaction impurity is soluble in water.
The used hyaluronic molecular weight of the present invention can be 5.0 * 10
5Da-2.1 * 10
6Da, preferred molecular weight is 1.5 * 10
6Da; The granularity of used sodium alginate powder is 50 orders-300 orders, is preferably 200 orders.
The present invention is in the presence of carboxyl activator, and to carry out amidate action crosslinked and make hardness, visco-elasticity mucinase-sodium-alginate composite cross-linked polymer preferably by having two or more amino superpolymer or oligopolymer (linking agent) and mucinase, sodium-alginate in the molecular structure.The composite crosslinking hydrogel that obtains possesses the two-fold advantage of HA and SAL, and on the one hand, the ability of antienzyme degraded is improved, and on the other hand, the mechanical properties of hydrogel and matter structure characteristic improve.After the physicochemical property of composite crosslinking hydrogel are improved, have as the potential use of corium weighting material and tissue stent material and be used for surgical operation, field of tissue engineering technology.
Description of drawings
Fig. 1 prepares the process flow sheet of mucinase-sodium-alginate composite aquogel for the present invention.
Fig. 2 is the infrared spectrogram of the mucinase-sodium-alginate composite aquogel of embodiment 1 preparation.
Embodiment
Through specific embodiment method of the present invention is described below, but the present invention is not limited thereto.
Experimental technique described in the following embodiment like no specified otherwise, is ordinary method; Said reagent and material like no specified otherwise, all can obtain from commercial sources.
The preparation of embodiment 1, mucinase-sodium-alginate hydrogel and physicochemical property checking thereof
Prepare mucinase-sodium-alginate hydrogel according to process flow sheet shown in Figure 1, concrete steps are following:
1. polysaccharide dissolving: molecular weight is 1.5 * 10
6(particle diameter is 200 mesh sieves for the mucinase of Da (Furuida Biochemical Co., Ltd., Shandong) and sodium-alginate; The aqueous solution of 10mg/ml; Its viscosity is 205mPas in the time of 25 ℃; The brilliant rock bio tech ltd in Qingdao) soluble in water with 1: 2 ratio (mass ratio), make that its total concn is 1.0% (g/100ml), obtain solution 1.
2. add linking agent and regulator solution pH: after treating that polysaccharide during step 1. dissolves fully, linking agent ADH (Beijing JinYuan Chemical Group Co.,Ltd) is added in the said solution 1 with the proportioning of 0.52g: 100ml, mix.And above-mentioned mixing solutions is carried out pH adjust, HAc-NaAc damping fluid (pH 3.6) the adjustment pH to 4.75 with 0.1mol/L obtains solution 2.
3. add the carboxyl activator: add EDC (Shanghai covalent chemical ltd) to solution 2, make its EDC concentration reach 50mmol/L.
4. stir and react and control pH: the reaction solution of step in 3. stirred and control pH, promptly begin to stir when adding EDC, stirring velocity should not be too fast, avoids the gel shear shinning that forms.At room temperature stir 4h, in the reaction process, make the pH value of reaction solution remain on 4.75, obtain mucinase and sodium-alginate composite aquogel through the HAc-NaAc damping fluid that drips 0.1mol/L.
5. gel detergent: to the composite aquogel that 4. step forms, use the deionized water repetitive scrubbing, washing times should be no less than 5 times, washs more than 20 minutes at every turn, and the gel that slowly overturns during washing makes residual reaction impurity soluble in water and remove.
6. gel is preserved: the gel after 5. step is washed is preserved down at 4 ℃.
The mucinase that makes according to the method described above-sodium-alginate composite aquogel is colourless, has certain rigidity and visco-elasticity.
Characteristic to mucinase one sodium-alginate composite aquogel is measured: (Nicolet Nexus, Thermo Electron USA) measure whether form covalent linkage 1, to adopt the FT-IR spectrograph; 2, (Hitachi SEM-2500 Japan) observes the microstructure that forms gel to adopt ESEM; 3, adopt matter structure appearance that the matter structure characteristic of gel is measured (pre test speed 2.0mm/s; Test speed 0.8mm/s, post test speed 2.0mm/s, rupture test distance 4.0%; Distance 50%, 25 ℃ of temperature .).
Infrared spectrogram is seen Fig. 2, measures result's new covalent linkage that shown gel formation, and it is crosslinked together that mucinase and sodium-alginate pass through adipic dihydrazide (ADH).ESEM shows, forms in the gel evenly and the suitable reticulated structure in aperture.Matter structure appearance (Cns-Farnell, Britain) recording gel hardness is 357.06g, and cracked degree is 253.56g, and elasticity is 0.961.
Swell test:
Gel behind the vacuum-freeze-dry, weighing is placed on 12h in the deionized water, behind the water with filter paper removal surface, weighs, and the result shows that the gel suction can reach 40-50 times that self weighs.
Antienzyme degraded test:
It is the Unidasa liquid of 10U/ml that gel sample places the 10ml enzyme activity, and every interval 3h therefrom gets the 1ml supernatant and measures, and the Unidasa liquid that replenishes the new preparation of 1ml then is to reaction system.Measuring method is following: the dense H of 5mL
2SO
4Place test tube and be cooled to 4 ℃, 1mL appearance liquid or reference liquid place dense H carefully
2SO
4On the layer, begin jolting gently, then shaken; And make it constantly cooling in ice bath, and next test tube is heated 10min in ebullient zero(ppm) water, be cooled to room temperature then; Add 0.2mL carbazole test solution, shake up once more, and in boiling water bath, heat 15min; Be cooled to room temperature, reaction solution is poured in the 1cm cuvette, under 530nm, measure absorbancy (A530).Through hyaluronic acid contents in the standard curve determination solution.According to the formula calculated for gel by the zymolytic degree of mucinase:
Wi＝C
iV+∑C
i-1V
s
Wherein, C
iAnd C
I-1Be the HA concentration (mg/ml) of gel under i and i-1 are decomposed constantly, V is an enzyme liquid TV (10ml), and Vs is each sample volume (1ml) that takes out.
The result shows that along with the prolongation in treatment time, gel is decomposed by Unidasa gradually, when 9h, almost be decomposed fully, and the hyaluronic acid derivatives of control group promptly is decomposed behind 3h fully.
The preparation of embodiment 2, mucinase-sodium-alginate hydrogel and physicochemical property checking thereof
Prepare mucinase-sodium-alginate hydrogel according to process flow sheet shown in Figure 1, concrete steps are following:
1. polysaccharide dissolving: molecular weight is 5.0 * 10
5(particle diameter is 50 mesh sieves for the mucinase of Da (Furuida Biochemical Co., Ltd., Shandong) and sodium-alginate; The aqueous solution of 10mg/ml; Its viscosity is 100mPas in the time of 25 ℃; The brilliant rock bio tech ltd in Qingdao) soluble in water with 1: 4 ratio (mass ratio), make that its total concn is 0.5% (g/100ml), obtain solution 1.
2. add linking agent and regulator solution pH: after treating that polysaccharide during step 1. dissolves fully, linking agent ADH (Beijing JinYuan Chemical Group Co.,Ltd) is added in the said solution 1 with the proportioning of 0.1g: 100ml, mix.And above-mentioned mixing solutions is carried out pH adjust, HAc-NaAc damping fluid (pH 3.6) the adjustment pH to 4.75 with 0.1mol/L obtains solution 2.
3. add the carboxyl activator: add EDC (Shanghai covalent chemical ltd) to solution 2, make its EDC concentration reach 10mmol/L.
4. stir and react and control pH: the reaction solution of step in 3. stirred and control pH, promptly begin to stir when adding EDC, stirring velocity should not be too fast, avoids the gel shear shinning that forms.At room temperature stir 4h, in the reaction process, make the pH value of reaction solution remain on 4.75, obtain mucinase and sodium-alginate composite aquogel through the HAc-NaAc damping fluid that drips 0.1mol/L.
5. gel detergent: to the composite aquogel that 4. step forms, use the deionized water repetitive scrubbing, washing times should be no less than 5 times, washs more than 20 minutes at every turn, and the gel that slowly overturns during washing makes residual reaction impurity soluble in water and remove.
6. gel is preserved: the gel after 5. step is washed is preserved down at 4 ℃.
The mucinase that makes according to the method described above-sodium-alginate composite aquogel is colourless, has certain rigidity and visco-elasticity.
Infrared measurement shows, gel formation new covalent linkage, mucinase and sodium-alginate are crosslinked together through adipic dihydrazide (ADH).ESEM shows, forms in the gel evenly and the suitable reticulated structure in aperture.Matter structure appearance (Cns-Farnell, Britain) recording gel hardness is 71.02g, and cracked degree is 66.89g, and elasticity is 0.97.
Swell test:
Gel behind the vacuum-freeze-dry, weighing is placed on 12h in the deionized water, remove the water on surface with filter paper after, weigh, the result shows, the gel suction can reach that self is heavy 55 times.
Antienzyme degraded test:
It is the Unidasa liquid of 10U/ml that gel sample places the 10ml enzyme activity, and every interval 3h therefrom gets the 1ml supernatant and measures.
The result shows that along with the prolongation in treatment time, gel is decomposed by Unidasa gradually, when 6h, almost be decomposed fully, and the hyaluronic acid derivatives of control group promptly is decomposed behind 3h fully.
The preparation of embodiment 3, mucinase-sodium-alginate hydrogel and physicochemical property checking thereof
Prepare mucinase-sodium-alginate hydrogel according to process flow sheet shown in Figure 1, concrete steps are following:
1. polysaccharide dissolving: molecular weight is 2.1 * 10
6(particle diameter is 300 mesh sieves for the mucinase of Da (Furuida Biochemical Co., Ltd., Shandong) and sodium-alginate; The aqueous solution of 10mg/ml; Its viscosity is 300mPas in the time of 25 ℃; The brilliant rock bio tech ltd in Qingdao) soluble in water with 4: 1 ratios (mass ratio), make that its total concn is 1.5% (g/100ml), obtain solution 1.
2. add linking agent and regulator solution pH: after treating that polysaccharide during step 1. dissolves fully, linking agent ADH (Beijing JinYuan Chemical Group Co.,Ltd) is added in the said solution 1 with the proportioning of 1.0g: 100ml, mix.And above-mentioned mixing solutions is carried out pH adjust, HAc-NaAc damping fluid (pH 3.6) the adjustment pH to 4.75 with 0.1mol/L obtains solution 2.
3. add the carboxyl activator: add EDC (Shanghai covalent chemical ltd) to solution 2, make its EDC concentration reach 100mmol/L.
4. stir and react and control pH: the reaction solution of step in 3. stirred and control pH, promptly begin to stir when adding EDC, stirring velocity should not be too fast, avoids the gel shear shinning that forms.At room temperature stir 4h, in the reaction process, make the pH value of reaction solution remain on 4.75, obtain mucinase and sodium-alginate composite aquogel through the HAc-NaAc damping fluid that drips 0.1mol/L.
5. gel detergent: to the composite aquogel that 4. step forms, use the deionized water repetitive scrubbing, washing times should be no less than 5 times, washs more than 20 minutes at every turn, and the gel that slowly overturns during washing makes residual reaction impurity soluble in water and remove.
6. gel is preserved: the gel after 5. step is washed is preserved down at 4 ℃.
The mucinase that makes according to the method described above-sodium-alginate composite aquogel is colourless, has certain rigidity and visco-elasticity.
Infrared measurement shows, gel formation new covalent linkage, mucinase and sodium-alginate are crosslinked together through adipic dihydrazide (ADH).ESEM shows, forms in the gel evenly and the suitable reticulated structure in aperture.Matter structure appearance (Cns-Farnell, Britain) recording gel hardness is 209.50g, and cracked degree is 190.28g, and elasticity is 1.14.
Swell test:
Gel behind the vacuum-freeze-dry, weighing is placed on 12h in the deionized water, remove the water on surface with filter paper after, weigh, the result shows, the gel suction can reach that self is heavy 20 times.
Antienzyme degraded test:
It is the Unidasa liquid of 10U/ml that gel sample places the 10ml enzyme activity, and every interval 3h therefrom gets the 1ml supernatant and measures.
The result shows that along with the prolongation in treatment time, gel is decomposed by Unidasa gradually, when 8h, almost be decomposed fully, and the hyaluronic acid derivatives of control group promptly is decomposed behind 3h fully.
Claims (10)
1. the preparation method of mucinase and sodium-alginate composite aquogel comprises the steps:
1) mucinase and sodium-alginate is soluble in water, obtain solution 1,
2) linking agent is added in the said solution 1, and use buffered soln adjusting pH value to be 4.0-5.5, obtain solution 2;
3) in said solution 2, add carboxyl activator and stirring, the pH value of regulating and control said solution 2 with buffered soln in the whipping process until forming gel, promptly obtains mucinase and sodium-alginate composite aquogel at 2.0-5.5.
2. method according to claim 1 is characterized in that: the mass ratio of mucinase and sodium-alginate is 1 in the said solution 1: 4-4: 1; The concentration sum of mucinase and sodium-alginate is 0.5-1.5g/100ml in the said solution 1.
3. method according to claim 1 and 2 is characterized in that: step 2) described in linking agent be selected from following at least a: adipic dihydrazide, polyoxyethylene glycol, LUTARALDEHYDE and divinylsulfone; The proportioning of the add-on of said linking agent and said solution 1 is 0.1g-1.0g: 100mL.
4. method according to claim 1 is characterized in that: the activator of carboxyl described in the step 3) is selected from following at least a: carbodiimide, N-hydroxy-succinamide and N, N, N ", a N " Tetramethyl Ethylene Diamine; The proportioning of the addition of said carbodiimide and said solution 2 is 10mmol-100mmol: 1L.
5. method according to claim 1 is characterized in that: be stirred in described in the step 3) under 15 ℃ of-40 ℃ of conditions and carry out; The pH value of regulation and control solution 2 is 4.75 in the said whipping process.
6. method according to claim 1; It is characterized in that: step 2) identical with buffered soln described in the step 3); Be selected from following any one: phosphate buffer soln; Citrate buffer solution and acetate buffer solution, the concentration of said buffered soln are 0.01-0.5mol/L, and the pH value is 2.0-4.5.
7. method according to claim 6 is characterized in that: step 2) and step 3) described in buffered soln be that concentration is that 0.1mol/L, pH value are 3.6 acetate buffer.
8. method according to claim 1 is characterized in that: said hyaluronic molecular weight is 5.0 * 10
5-2.1 * 10
6Da; The granularity of said sodium-alginate is 50 orders-300 orders.
9. method according to claim 1 is characterized in that: said method also comprises the step that mucinase that step 3) is obtained and sodium-alginate composite aquogel water wash.
10. arbitrary said method prepares among the claim 1-9 mucinase and sodium-alginate composite aquogel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102376051A CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102376051A CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102070786A CN102070786A (en) | 2011-05-25 |
| CN102070786B true CN102070786B (en) | 2012-05-30 |
Family
ID=44029558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102376051A Expired - Fee Related CN102070786B (en) | 2009-11-19 | 2009-11-19 | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102070786B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102409731B1 (en) | 2020-04-03 | 2022-06-15 | 한양대학교 산학협력단 | Dual cross-linked self-healing hydrogel |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102391537B (en) * | 2011-07-15 | 2013-06-05 | 厦门大学 | Multilayer aquagel, and preparation method and application thereof |
| CN102532564B (en) * | 2012-01-16 | 2013-09-25 | 孙珊 | Hydrogel and preparation method thereof |
| CN102657871B (en) * | 2012-05-04 | 2014-01-01 | 中国药科大学 | Oral slow release preparation, entrapment material and preparation method |
| CN103550830A (en) * | 2013-10-15 | 2014-02-05 | 北京大学 | Alginic acid-hyaluronic acid in situ tissue engineering cell scaffold and its preparation method |
| CN104004232A (en) * | 2014-05-07 | 2014-08-27 | 沈阳师范大学 | Biodegradable chitosan-based hydrogel and preparation method thereof |
| CN104861178A (en) * | 2015-05-26 | 2015-08-26 | 西北大学 | Pullulan-hyaluronic acid hydrogel and preparation method thereof |
| CN105330902A (en) * | 2015-11-20 | 2016-02-17 | 清华大学 | Hyaluronic acid-methyl cellulose composite hydrogel as well as preparation and application thereof |
| EP3397650A1 (en) * | 2015-12-29 | 2018-11-07 | Galderma S.A. | Hydrolysis of ester bonds in amide crosslinked glycosaminoglycans |
| CN106750383B (en) * | 2016-12-20 | 2019-02-12 | 大连理工大学 | Polyethylene glycol hydrogel material and preparation method thereof |
| CN106620825B (en) * | 2016-12-26 | 2019-11-12 | 浙江大学 | A kind of bi-component quick-acting haemostatic powder gel and its application |
| CN108192164A (en) * | 2017-12-29 | 2018-06-22 | 安徽天星电缆科技有限公司 | A kind of good torsion cable for robot arm material of thermal stability |
| CN110734745B (en) * | 2019-11-28 | 2021-08-17 | 浙江海洋大学 | Cold chain coolant for tuna and preparation method thereof |
| CN111019195B (en) * | 2019-12-12 | 2021-12-14 | 武汉纺织大学 | Self-healing hydrogel and preparation method thereof |
| CN111978600B (en) * | 2020-09-02 | 2022-07-01 | 山东华熙海御生物医药有限公司 | Hyaluronic acid composite gel for pacifying nipple |
| CN112121644B (en) * | 2020-10-19 | 2022-12-06 | 天津工业大学 | Preparation method of oxalic acid cross-linked alginate hydrogel filtering membrane and application of filtering membrane in molecular ion separation |
| CN112812330B (en) * | 2021-01-08 | 2022-07-22 | 青岛琛蓝海洋生物工程有限公司 | Compound polysaccharide sodium hyaluronate gel and preparation method thereof |
| CN114432234A (en) * | 2022-02-24 | 2022-05-06 | 浦易(上海)生物技术股份有限公司 | A gellable solution composition for obesity intervention, and its application method and application |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101874904A (en) * | 2009-12-02 | 2010-11-03 | 淄博高新区联创科技服务中心 | Method for preparing medicament-carrying tissue engineering hydrogel |
-
2009
- 2009-11-19 CN CN2009102376051A patent/CN102070786B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101874904A (en) * | 2009-12-02 | 2010-11-03 | 淄博高新区联创科技服务中心 | Method for preparing medicament-carrying tissue engineering hydrogel |
Non-Patent Citations (1)
| Title |
|---|
| JP特开平6-100468A 1994.04.12 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102409731B1 (en) | 2020-04-03 | 2022-06-15 | 한양대학교 산학협력단 | Dual cross-linked self-healing hydrogel |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102070786A (en) | 2011-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102070786B (en) | Hyaluronic acid-sodium alginate composite hydrogel and preparation method thereof | |
| Banks et al. | Chemical modification of alginate for controlled oral drug delivery | |
| JP3094074B2 (en) | Polysaccharide gel composition | |
| CN103613686B (en) | The preparation method of thiolated hyaluronic acid and application thereof | |
| US10077320B2 (en) | Process for preparing a cross-linked hyaluronic acid product | |
| JP5684154B2 (en) | Biomaterial for injection | |
| JPH08507713A (en) | Compositions and methods for tissue augmentation | |
| Oprea et al. | Cellulose/chondroitin sulfate hydrogels: Synthesis, drug loading/release properties and biocompatibility | |
| US11098168B2 (en) | Method for preparing cross-linked hyaluronic acid gel and cross-linked hyaluronic acid gel prepared by the same | |
| WO2006044342A2 (en) | Self-gelling alginate systems and uses thereof | |
| CN102718991A (en) | High strength injectable hydrogel and preparation method thereof | |
| CN110760103B (en) | Viscoelastic hydrogel and preparation method and application thereof | |
| CN1830420B (en) | Injection type pH sepsitive chitin quarternary ammonium salt aquagel and its preparation method | |
| CN110256669A (en) | Sulfydryl/boronate modified polymer, glucose-sensitive hydrogels composition, glucose-sensitive carry liquid medicine gel and preparation method thereof | |
| US6281341B1 (en) | Hetero-polysaccharide conjugate and methods of making and using the same | |
| CN106750416A (en) | A kind of injection aquagel for possessing self-healing and pH response performances and its preparation method and application | |
| JP2014528406A (en) | Multilayer implant for delivering therapeutic agents | |
| CN101537209A (en) | Preparation process and application of three-dimensional network structure medical use hydrogel particles | |
| CN109337098B (en) | Preparation method of enzyme-responsive colon-targeted drug-loaded gel | |
| CN109734937B (en) | Preparation method of VA @ PLGA-CS-HA/OHPPMC-HA antibacterial injectable hydrogel | |
| CN105820267B (en) | A kind of skin wound preparation for repairing and its preparation method and application | |
| CN110448727B (en) | Adhesive hydrogel material, suture-free artificial nerve conduit and preparation method thereof | |
| KR100474528B1 (en) | Thermo-sensitive Polysaccharide Copolymer and Method Thereof | |
| KR101132673B1 (en) | Ubiquitous Injectable, Thermo-Reversible Gel for Hydrophobic and Hydrophilic Drug Delivery | |
| CN105085708A (en) | Preparation method for original nature hyaluronic acid graft modified polymer and derivative thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20131119 |